Quanta Announces "Town Hall" Style Shareholder Update for September 10, 2020 at 1:30 PM ET

September 4, 2020 9:53 AM

BURBANK, CA / ACCESSWIRE / September 4, 2020 / Quanta, Inc. (OTC PINK:QNTA), an applied sciences company based on a quantum biology platform that significantly boosts the potency and efficiency of any plant-based matter, today announced another virtual "Town Hall" style investor event, which will be broadcast live over the internet on September 10, 2020 at 1:30 PM ET / 10:30 AM PT. Eric Rice, the company's Chief Executive...

Read more

Dania Scott Joins Tetra Bio-Pharma as Senior Vice President Commercial Strategy

September 4, 2020 8:00 AM

Brings over 20 years of commercial and medical expertise in the pharmaceutical industry and the cannabis space OTTAWA, ON / ACCESSWIRE / September 4, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, is excited to announce that Dania Scott has joined Tetra as the Senior Vice President Commercial Strategy. She will be the...

Read more

Pieris Pharmaceuticals to Participate in Upcoming Investor Conferences

September 3, 2020 4:30 PM

BOSTON, MA / ACCESSWIRE / September 3, 2020 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer, and other indications, today announced that members of the management team will participate in the following upcoming investor conferences and will provide a corporate update: Baird 2020...

Read more

Applied UV Announces Closing of $5,000,000 Initial Public Offering and Closing of $750,000 Overallotment

September 3, 2020 1:00 PM

MOUNT VERNON, NY / ACCESSWIRE / September 3, 2020 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of narrow-range ultra violet light ("UVC") to destroy pathogens safely, thoroughly, and automatically, today announced the closing of its initial public offering of 1,000,000 shares of its common stock at a price of $5.00 per share on...

Read more

Applied UV Announces Exercise of Over-Allotment Option

September 1, 2020 3:35 PM

MOUNT VERNON, NY / ACCESSWIRE / September 1, 2020 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of narrow-range ultra violet light ("UVC") to destroy pathogens safely, thoroughly, and automatically, today announced in connection with its previously announced initial public offering of its common stock, the exercise by Network 1...

Read more

DSwiss Announces New DNA Testing Business

September 1, 2020 11:25 AM

KUALA LUMPUR, MY / ACCESSWIRE / September 1, 2020 / DSwiss, Inc (OTCPINK:DQWS) today announced that it has ventured into the field of direct-to-consumer DNA Testing. DSwiss has developed an affordable DNA test which gives much insight about yourself, including a personalized and actionable step guide for people to pursue living a healthier and productive life. Our genes play an integral part in determining our health, but our lifestyle...

Read more

Oncocyte to Present at the LD 500 Virtual Conference

September 1, 2020 11:00 AM

LOS ANGELES, CA / ACCESSWIRE / September 1, 2020 / Oncocyte (NYSE American:OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced that it will be presenting at the LD 500 investor conference on Thursday, September 3rd at 12:20PM PST / 3:20PM EST. Mitch Levine (CFO) and Dr. Doug Ross (CMO) will be presenting to a live virtual...

Read more

Vivos Inc to Present at The LD 500 Virtual Conference

September 1, 2020 9:30 AM

LOS ANGELES, CA / ACCESSWIRE / September 1, 2020 / Vivos Inc (OTCQB:RDGL), a company that has developed an Yttrium-90 based injectable brachytherapy device, for the treatment of tumors in animals and in humans, today announced that it will be presenting at the LD 500 investor conference on Thursday September 3 at 1:40 PST / 4:00 PM EST. Dr. Mike Korenko (CEO of Vivos Inc) will be presenting to a live virtual audience. Register here:...

Read more

Helix BioPharma Corp. Provides Polish Subsidiary Divestiture Update

August 31, 2020 5:00 PM

RICHMOND HILL, ON / ACCESSWIRE / August 31, 2020 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based on its proprietary technological platform DOS47, today announced an update on the progress regarding the non-binding term sheet the Company received and previous announced on June 26, 2020 to divest the...

Read more

Applied UV Announces Pricing of $5 Million Initial Public Offering

August 31, 2020 11:10 AM

MOUNT VERNON, NY / ACCESSWIRE / August 31, 2020 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of narrow-range ultra violet light ("UVC") to destroy pathogens safely, thoroughly, and automatically, today announced the pricing of its initial public offering of 1,000,000 shares of its common stock at a price of $5.00 per share. The...

Read more

Yulong Recruits Dr. Jason Sanders as CMO

August 31, 2020 9:00 AM

CHEYENNE, WY / ACCESSWIRE / August 31, 2020 / Yulong Eco-Materials Limited (OTC PINK:YECO) today announced that it has engaged Dr. Jason Sanders as Chief Medical Officer. Dr. Sanders is an expert in the science and medicine of extracellular vesicles (EVs) including exosome-based diagnostic and therapeutic technology. As an honors graduate from Harvard University, Dr. Sanders concentrated in molecular biochemistry, cellular signaling and...

Read more

CEL-SCI Corporation to Present at The LD 500 Virtual Conference

August 31, 2020 9:00 AM

VIENNA, VA / ACCESSWIRE / August 31, 2020 / CEL-SCI Corporation (NYSE American:CVM), a Phase 3 cancer immunotherapy company, today announced that it will be presenting at the LD 500 investor conference on Wednesday, September 2nd at 10:20 a.m. ET. Geert Kersten, Chief Executive Officer of CEL-SCI, will be presenting to a live virtual audience. A live audio webcast of the chat will be available at...

Read more

Omnicanna CEO, Greta Gaines with Kelly Carroll from The Fly, Examine the Hempery Brands' Successful Focus on Health and Wellness, the Corona Virus Outbreak and Potential Cannabinoid Solutions, High-Tech Infusions, and Being a Part of the CSi-EDP Economic Development Plan Management Team

August 31, 2020 8:05 AM

RALEIGH, NC / ACCESSWIRE / August 31, 2020 / Omnicanna Health Solutions, Inc. (OTC PINK:ENDO), a U.S. Company specializing in Industrial Hemp Commercialization and Formulation-based health and wellness solutions, is pleased to release Omnicanna CEO Greta Gaines does an interview with Kelly Carroll from The Fly. Greta provides insight to industrial hemp commercialization and her passion to produce 100% natural health and wellness solutions,...

Read more

Yield10 Bioscience to Present at the LD 500 Virtual Conference on September 2, 2020

August 27, 2020 9:00 AM

WOBURN, MA / ACCESSWIRE / August 27, 2020 / Yield10 Bioscience, Inc. (NASDAQ:YTEN), an agricultural bioscience company, today announced that Oliver Peoples, Ph.D., President and Chief Executive Officer of Yield10, will give a virtual corporate presentation at the LD 500 Virtual Conference on Wednesday, September 2, 2020 at 1:20 pm ET, Track 2, followed by a live Q&A session with registered investors and other conference attendees. The...

Read more

Milestone Scientific to Present at The LD 500 Virtual Conference on September 1st

August 27, 2020 8:30 AM

ROSELAND, NJ / ACCESSWIRE / August 27, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug instruments that provide painless and precise injections, today announced that it will be presenting at The LD 500 Investor conference being held virtually on September 1-4, 2020. Len Osser, Interim Chief Executive Officer, is scheduled to present on Tuesday, September 1st at 2:40 p.m., Eastern Time. The...

Read more

Tetra Bio-Pharma Announces Data on its CBD Metabolite Study in Humans

August 27, 2020 8:00 AM

Tetra defines CBD Metabolism in Humans Following QIXLEEF™ Inhalation Data from metabolite study provides explanation for inhalation as a safe route of administration OTTAWA, ON / ACCESSWIRE / August 27, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP)(OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, today announced that it has mapped out CBD metabolites...

Read more

Artelo Biosciences to Present at The LD 500 Virtual Investor Conference on September 1st

August 26, 2020 9:30 AM

LA JOLLA, CA / ACCESSWIRE / August 26, 2020 / Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate the endocannabinoid system, today announced that it will be presenting at the LD 500 Virtual Investor conference being held on September 1-4, 2020. View Artelo's LD Micro profile here: https://www.ldmicro.com/profile/artl. Gregory D. Gorgas, President and Chief Executive...

Read more

GB Sciences Files Provisional Patent Application for the Treatment of COVID-19-Related Acute Respiratory Distress Syndrome (ARDS), the Leading Cause of Hospitalization and Deaths, Utilizing Its Cannabinoid Containing Complex Mixtures (CCCM(TM))

August 26, 2020 9:00 AM

LAS VEGAS, NV / ACCESSWIRE / August 26, 2020 / GB Sciences, Inc. (OTCQB:GBLX) has filed a provisional patent application, assigned to GBS Global Biopharma (GBS), Inc., for the use of its new proprietary cannabinoid containing complex mixtures (CCCM™) for the treatment of Cytokine Storm Syndromes (CSS), including acute respiratory distress syndrome (ARDS) in COVID-19 patients. CSS and ARDS are the leading cause of death in COVID-19. Based...

Read more

Genprex to Present at The LD 500 Virtual Conference

August 26, 2020 8:17 AM

AUSTIN, TX / ACCESSWIRE / August 26, 2020 / Genprex, Inc. ("Genprex" or the "Company") (NASDAQ:GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced that it will be presenting at the LD 500 Virtual Investor Conference on Tuesday, September 1, 2020 at 1:20 p.m. ET. Rodney Varner, Chairman and Chief Executive Officer of...

Read more

electroCore to Present at The LD 500 Virtual Conference

August 26, 2020 8:00 AM

LOS ANGELES, CA / ACCESSWIRE / August 26, 2020 / electroCore Inc, (NASDAQ:ECOR), a commercial-stage bioelectronic medicine company, today announced that it will be presenting at the LD 500 investor conference on Thursday, September 3rd at 6:20 AM PST / 9:20 AM EST. Dan Goldberger, Chief Executive Officer of electroCore, will be presenting to a live audience. Register here: https://ld-micro-conference.events.issuerdirect.com/ "We have...

Read more